Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Nurse Practitioner · HAMILTON, OH · NPI 1841545993
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 472 | 164 |
| Atorvastatin Calcium | Atorvastatin Calcium | 459 | 163 |
| Lisinopril | Lisinopril | 349 | 122 |
| Losartan Potassium | Losartan Potassium | 307 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 271 | 90 |
| Omeprazole | Omeprazole | 246 | 76 |
| Metformin Hcl | Metformin Hcl | 244 | 86 |
| Hydrochlorothiazide | Hydrochlorothiazide | 213 | 70 |
| Duloxetine Hcl | Duloxetine Hcl | 208 | 66 |
| Metoprolol Succinate | Metoprolol Succinate | 207 | 66 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 199 | 67 |
| Gabapentin | Gabapentin | 180 | 65 |
| Pantoprazole Sodium | Pantoprazole Sodium | 155 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 154 | 47 |
| Furosemide | Furosemide | 151 | 65 |
| Escitalopram Oxalate | Escitalopram Oxalate | 148 | 59 |
| Tamsulosin Hcl | Tamsulosin Hcl | 130 | 45 |
| Trazodone Hcl | Trazodone Hcl | 130 | 48 |
| Ozempic | Semaglutide | 126 | 40 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 116 | 42 |
| Simvastatin | Simvastatin | 112 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 107 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 103 | 47 |
| Tizanidine Hcl | Tizanidine Hcl | 102 | 49 |
| Sertraline Hcl | Sertraline Hcl | 85 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | 26 |
| Carvedilol | Carvedilol | 78 | 29 |
| Montelukast Sodium | Montelukast Sodium | 78 | 25 |
| Lovastatin | Lovastatin | 76 | 23 |
| Glimepiride | Glimepiride | 67 | 25 |
| Alendronate Sodium | Alendronate Sodium | 66 | 29 |
| Spironolactone | Spironolactone | 61 | 23 |
| Donepezil Hcl | Donepezil Hcl | 57 | 18 |
| Allopurinol | Allopurinol | 56 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 56 | 20 |
| Prednisone | Prednisone | 54 | 44 |
| Eliquis | Apixaban | 53 | 22 |
| Jardiance | Empagliflozin | 52 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 52 | 19 |
| Promethazine Hcl | Promethazine Hcl | 49 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 45 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 43 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 43 | 12 |
| Clonidine Hcl | Clonidine Hcl | 42 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | 34 |
| Buspirone Hcl | Buspirone Hcl | 39 | 17 |
| Methotrexate | Methotrexate Sodium | 39 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | 13 |
| Potassium Chloride | Potassium Chloride | 37 | 16 |
| Trulicity | Dulaglutide | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 36 | 11 |
| Synthroid | Levothyroxine Sodium | 36 | 13 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | 14 |
| Sumatriptan Succinate | Sumatriptan Succinate | 34 | suppressed |
| Finasteride | Finasteride | 33 | 12 |
| Valsartan | Valsartan | 33 | suppressed |
| Famotidine | Famotidine | 32 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 32 | 12 |
| Warfarin Sodium | Warfarin Sodium | 32 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 31 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Primidone | Primidone | 30 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 30 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 30 | 11 |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Atenolol | Atenolol | 27 | 11 |
| Pregabalin | Pregabalin | 26 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 25 | suppressed |
| Estradiol | Estradiol | 25 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 23 | 13 |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Nystatin | Nystatin | 23 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Meloxicam | Meloxicam | 21 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 12 |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 11 |
| Lacosamide | Lacosamide | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error